Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-CLOBETASOL SHAMPOO TARO PHARMACEUTICALS INC Resolved 0.05% Updated Report 2024-06-12 227640
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE TARO PHARMACEUTICALS INC Resolved 1% 0.05% Updated Report 2024-06-12 227643
CLOTRIMADERM TOPICAL TARO PHARMACEUTICALS INC Resolved 1% Updated Report 2024-06-12 227648
TARO-DICLOFENAC TARO PHARMACEUTICALS INC Resolved 1.5% Updated Report 2024-06-12 227653
TARO-LURASIDONE TARO PHARMACEUTICALS INC Actual shortage 20MG Updated Report 2024-06-12 227656
MEGESTROL AA PHARMA INC Anticipated shortage 40MG New Report 2024-06-12 230221
WINPRED AA PHARMA INC Anticipated shortage 1MG New Report 2024-06-12 230218
TETRACYCLINE AA PHARMA INC Actual shortage 250MG Updated Report 2024-06-12 227333
PINAVERIUM AA PHARMA INC Actual shortage 50MG Updated Report 2024-06-12 228794
THALOMID BRISTOL-MYERS SQUIBB CANADA Actual shortage 50MG Updated Report 2024-06-12 228619

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FOSRENOL TAKEDA CANADA INC Discontinued 500MG Updated Report 2024-06-10 228178
GLUCONORM 2.0MG NOVO NORDISK CANADA INC To be discontinued 2.0MG Updated Report 2024-06-05 201489
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-06-04 204160
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 100MG New Report 2024-06-04 229623
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 50MG New Report 2024-06-04 229620
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-06-03 228169
BUPIVACAINE HYDROCHLORIDE INJECTION, USP STERIMAX INC Discontinued 7.5MG Updated Report 2024-06-01 216017
AVAPRO SANOFI-AVENTIS CANADA INC To be discontinued 75MG New Report 2024-05-31 229306
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 50MG Updated Report 2024-05-17 228155
FOSRENOL TAKEDA CANADA INC To be discontinued 1000MG New Report 2024-05-16 228184
FOSRENOL TAKEDA CANADA INC To be discontinued 750MG New Report 2024-05-16 228181
EYE STREAM ALCON CANADA INC Discontinued 0.03% 0.048% 0.075% 0.64% New Report 2024-05-15 228021